Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.

Quotes for Spermosens AB (publ)

Right Now

+/-
-0.4
%
-1,82%
Latest
21.6
High
22
Low
21.4
Volume
31 967
Turnover (SEK)
691 783
Value (MSEK)
227,0

Board

CEO

  • John Lempert

Chairperson of the Board

  • Eva Nilsagård

Board

  • Ingela Liljeqvist Soltic
  • John Moll
  • Kushagr Punyani
  • Sören Melsing Frederiksen

Videos

Largest Owners

Name Capital % Votes % Date
Kushagr Punyani 15,02 15,02 2021-12-31
Avanza Pension 11,87 11,87 2021-12-31
Mohamad Takwa 8,55 8,55 2021-12-31
Nordnet Pensionsförsäkring 4,40 4,40 2021-12-31
Emelie Takwa 4,25 4,25 2021-12-31
Johan Källstrand 2,95 2,95 2021-12-31
John Moll 2,20 2,20 2021-09-30
Søren Melsing Frederiksen 2,09 2,09 2021-09-30
John Lempert 1,33 1,33 2021-12-31
Philip Rasmusson 1,33 1,33 2021-12-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Upcoming reports

  • 2022-02-10 Bokslutskommuniké 2021

  • 2022-05-05 Delårsrapport 2022-Q1

  • 2022-08-18 Delårsrapport 2022-Q2

  • 2022-11-10 Delårsrapport 2022-Q3